Puregene Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 17-07-2024
- Paid Up Capital ₹ 1.45 Cr
as on 17-07-2024
- Company Age 25 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 2.85 Cr
as on 17-07-2024
- Revenue %
(FY 2023)
- Profit 255.98%
(FY 2023)
- Ebitda -0.74%
(FY 2023)
- Net Worth 4.89%
(FY 2023)
- Total Assets 8.27%
(FY 2023)
About Puregene Biotech
The Corporate was formerly known as Simran Breeders Pvt Ltd. The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.45 Cr.
The company has closed loans amounting to ₹2.85 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Kawaljeet Bhatia, Harender Bhatia, and Gurmeet Bhatia serve as directors at the Company.
- CIN/LLPIN
U01222MP1999PLC013303
- Company No.
013303
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
11 Feb 1999
- Date of AGM
31 Jul 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Puregene Biotech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kawaljeet Bhatia  | Director | 01-Apr-2002 | Current |
| Harender Bhatia | Director | 11-Feb-1999 | Current |
| Gurmeet Bhatia | Director | 11-Feb-1999 | Current |
Financial Performance of Puregene Biotech.
Puregene Biotech Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 255.98% increase in profit. The company's net worth moved up by a moderate rise of 4.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Puregene Biotech?
In 2023, Puregene Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Simran Hatcheries Private LimitedActive 33 years 19 daysKawaljeet Bhatia, Harender Bhatia and 1 more are mutual person
Simran Farms LimitedActive 40 years 2 monthsKawaljeet Bhatia, Harender Bhatia and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of Baroda Creation Date: 30 Mar 2004 | ₹3.59 M | Satisfied |
Bank Of Baroda Creation Date: 30 Dec 1999 | ₹1.20 M | Satisfied |
Bank Of Baroda Creation Date: 30 Dec 1999 | ₹1.58 Cr | Satisfied |
How Many Employees Work at Puregene Biotech?
Unlock and access historical data on people associated with Puregene Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Puregene Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Puregene Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
